世界のI型高リポタンパク血症薬市場：専門的調査

• 英文タイトル：Global Type I Hyperlipoproteinemia Drug Market Professional Survey Report 2019

• レポートコード：QYR9ST15195
• 出版社/出版日：QYResearch / 2019年9月10日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、100ページ
• 納品方法：Eメール（受注後2-3営業日）
• 産業分類：医薬品・医療

• 販売価格（消費税別）

Single User	￥518,000 (USD3,500)	▷ お問い合わせ
Enterprise License	￥1,036,000 (USD7,000)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

※本調査レポートは、I型高リポタンパク血症薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、アリポジーン・チパルボベック、CAT-2003、ISIS-APOCIIIRx、メシル酸ロミタピド、プラジガスタットナトリウム、その他に、用途別には、病院、診療所、その他にセグメント区分し、I型高リポタンパク血症薬の世界市場を分析しました。

・エグゼクティブ・サマリー
・I型高リポタンパク血症薬の世界市場概要
・I型高リポタンパク血症薬の製造コスト構成分析
・I型高リポタンパク血症薬の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・I型高リポタンパク血症薬の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・I型高リポタンパク血症薬のセグメント分析（種類別）
（アリポジーン・チパルボベック、CAT-2003、ISIS-APOCIIIRx、メシル酸ロミタピド、プラジガスタットナトリウム、その他）
・I型高リポタンパク血症薬のセグメント分析（用途別）
（病院、診療所、その他）
・I型高リポタンパク血症薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Aegerion Pharmaceuticals, Inc.、Catabasis Pharmaceuticals, Inc.、Isis Pharmaceuticals, Inc.、Novartis AG、uniQure N.V.）
・I型高リポタンパク血症薬の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...

The global Type I Hyperlipoproteinemia Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Type I Hyperlipoproteinemia Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Type I Hyperlipoproteinemia Drug market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Type I Hyperlipoproteinemia Drug in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Type I Hyperlipoproteinemia Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Aegerion Pharmaceuticals, Inc.
Catabasis Pharmaceuticals, Inc.
Isis Pharmaceuticals, Inc.
Novartis AG
uniQure N.V.
…

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Alipogene Tiparvovec
CAT-2003
ISIS-APOCIIIRx
Lomitapide Mesylate
Pradigastat Sodium
Others

Segment by Application
Hospital
Clinic
Others

レポート目次

Table of Contents

Executive Summary
1 Industry Overview of Type I Hyperlipoproteinemia Drug
1.1 Definition of Type I Hyperlipoproteinemia Drug
1.2 Type I Hyperlipoproteinemia Drug Segment by Type
1.2.1 Global Type I Hyperlipoproteinemia Drug Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Alipogene Tiparvovec
1.2.3 CAT-2003
1.2.4 ISIS-APOCIIIRx
1.2.5 Lomitapide Mesylate
1.2.6 Pradigastat Sodium
1.2.7 Others
1.3 Type I Hyperlipoproteinemia Drug Segment by Applications
1.3.1 Global Type I Hyperlipoproteinemia Drug Consumption Comparison by Applications (2014-2025)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Type I Hyperlipoproteinemia Drug Overall Market
1.4.1 Global Type I Hyperlipoproteinemia Drug Revenue (2014-2025)
1.4.2 Global Type I Hyperlipoproteinemia Drug Production (2014-2025)
1.4.3 North America Type I Hyperlipoproteinemia Drug Status and Prospect (2014-2025)
1.4.4 Europe Type I Hyperlipoproteinemia Drug Status and Prospect (2014-2025)
1.4.5 China Type I Hyperlipoproteinemia Drug Status and Prospect (2014-2025)
1.4.6 Japan Type I Hyperlipoproteinemia Drug Status and Prospect (2014-2025)
1.4.7 Southeast Asia Type I Hyperlipoproteinemia Drug Status and Prospect (2014-2025)
1.4.8 India Type I Hyperlipoproteinemia Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Type I Hyperlipoproteinemia Drug
2.3 Manufacturing Process Analysis of Type I Hyperlipoproteinemia Drug
2.4 Industry Chain Structure of Type I Hyperlipoproteinemia Drug

3 Development and Manufacturing Plants Analysis of Type I Hyperlipoproteinemia Drug
3.1 Capacity and Commercial Production Date
3.2 Global Type I Hyperlipoproteinemia Drug Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Type I Hyperlipoproteinemia Drug
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Type I Hyperlipoproteinemia Drug Production and Capacity Analysis
4.2 Type I Hyperlipoproteinemia Drug Revenue Analysis
4.3 Type I Hyperlipoproteinemia Drug Price Analysis
4.4 Market Concentration Degree

5 Type I Hyperlipoproteinemia Drug Regional Market Analysis
5.1 Type I Hyperlipoproteinemia Drug Production by Regions
5.1.1 Global Type I Hyperlipoproteinemia Drug Production by Regions
5.1.2 Global Type I Hyperlipoproteinemia Drug Revenue by Regions
5.2 Type I Hyperlipoproteinemia Drug Consumption by Regions
5.3 North America Type I Hyperlipoproteinemia Drug Market Analysis
5.3.1 North America Type I Hyperlipoproteinemia Drug Production
5.3.2 North America Type I Hyperlipoproteinemia Drug Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Type I Hyperlipoproteinemia Drug Import and Export
5.4 Europe Type I Hyperlipoproteinemia Drug Market Analysis
5.4.1 Europe Type I Hyperlipoproteinemia Drug Production
5.4.2 Europe Type I Hyperlipoproteinemia Drug Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Type I Hyperlipoproteinemia Drug Import and Export
5.5 China Type I Hyperlipoproteinemia Drug Market Analysis
5.5.1 China Type I Hyperlipoproteinemia Drug Production
5.5.2 China Type I Hyperlipoproteinemia Drug Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Type I Hyperlipoproteinemia Drug Import and Export
5.6 Japan Type I Hyperlipoproteinemia Drug Market Analysis
5.6.1 Japan Type I Hyperlipoproteinemia Drug Production
5.6.2 Japan Type I Hyperlipoproteinemia Drug Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Type I Hyperlipoproteinemia Drug Import and Export
5.7 Southeast Asia Type I Hyperlipoproteinemia Drug Market Analysis
5.7.1 Southeast Asia Type I Hyperlipoproteinemia Drug Production
5.7.2 Southeast Asia Type I Hyperlipoproteinemia Drug Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Type I Hyperlipoproteinemia Drug Import and Export
5.8 India Type I Hyperlipoproteinemia Drug Market Analysis
5.8.1 India Type I Hyperlipoproteinemia Drug Production
5.8.2 India Type I Hyperlipoproteinemia Drug Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Type I Hyperlipoproteinemia Drug Import and Export

6 Type I Hyperlipoproteinemia Drug Segment Market Analysis (by Type)
6.1 Global Type I Hyperlipoproteinemia Drug Production by Type
6.2 Global Type I Hyperlipoproteinemia Drug Revenue by Type
6.3 Type I Hyperlipoproteinemia Drug Price by Type

7 Type I Hyperlipoproteinemia Drug Segment Market Analysis (by Application)
7.1 Global Type I Hyperlipoproteinemia Drug Consumption by Application
7.2 Global Type I Hyperlipoproteinemia Drug Consumption Market Share by Application (2014-2019)

8 Type I Hyperlipoproteinemia Drug Major Manufacturers Analysis
8.1 Aegerion Pharmaceuticals, Inc.
8.1.1 Aegerion Pharmaceuticals, Inc. Type I Hyperlipoproteinemia Drug Production Sites and Area Served
8.1.2 Aegerion Pharmaceuticals, Inc. Product Introduction, Application and Specification
8.1.3 Aegerion Pharmaceuticals, Inc. Type I Hyperlipoproteinemia Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Catabasis Pharmaceuticals, Inc.
8.2.1 Catabasis Pharmaceuticals, Inc. Type I Hyperlipoproteinemia Drug Production Sites and Area Served
8.2.2 Catabasis Pharmaceuticals, Inc. Product Introduction, Application and Specification
8.2.3 Catabasis Pharmaceuticals, Inc. Type I Hyperlipoproteinemia Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Isis Pharmaceuticals, Inc.
8.3.1 Isis Pharmaceuticals, Inc. Type I Hyperlipoproteinemia Drug Production Sites and Area Served
8.3.2 Isis Pharmaceuticals, Inc. Product Introduction, Application and Specification
8.3.3 Isis Pharmaceuticals, Inc. Type I Hyperlipoproteinemia Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Novartis AG
8.4.1 Novartis AG Type I Hyperlipoproteinemia Drug Production Sites and Area Served
8.4.2 Novartis AG Product Introduction, Application and Specification
8.4.3 Novartis AG Type I Hyperlipoproteinemia Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 uniQure N.V.
8.5.1 uniQure N.V. Type I Hyperlipoproteinemia Drug Production Sites and Area Served
8.5.2 uniQure N.V. Product Introduction, Application and Specification
8.5.3 uniQure N.V. Type I Hyperlipoproteinemia Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served

9 Development Trend of Analysis of Type I Hyperlipoproteinemia Drug Market
9.1 Global Type I Hyperlipoproteinemia Drug Market Trend Analysis
9.1.1 Global Type I Hyperlipoproteinemia Drug Market Size (Volume and Value) Forecast 2019-2025
9.2 Type I Hyperlipoproteinemia Drug Regional Market Trend
9.2.1 North America Type I Hyperlipoproteinemia Drug Forecast 2019-2025
9.2.2 Europe Type I Hyperlipoproteinemia Drug Forecast 2019-2025
9.2.3 China Type I Hyperlipoproteinemia Drug Forecast 2019-2025
9.2.4 Japan Type I Hyperlipoproteinemia Drug Forecast 2019-2025
9.2.5 Southeast Asia Type I Hyperlipoproteinemia Drug Forecast 2019-2025
9.2.6 India Type I Hyperlipoproteinemia Drug Forecast 2019-2025
9.3 Type I Hyperlipoproteinemia Drug Market Trend (Product Type)
9.4 Type I Hyperlipoproteinemia Drug Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Type I Hyperlipoproteinemia Drug Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Type I Hyperlipoproteinemia Drug
Table Global Type I Hyperlipoproteinemia Drug Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Type I Hyperlipoproteinemia Drug Production Market Share by Types in 2018
Figure Alipogene Tiparvovec Product Picture
Figure CAT-2003 Product Picture
Figure ISIS-APOCIIIRx Product Picture
Figure Lomitapide Mesylate Product Picture
Figure Pradigastat Sodium Product Picture
Figure Others Product Picture
Table Global Type I Hyperlipoproteinemia Drug Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Type I Hyperlipoproteinemia Drug Consumption Market Share by Applications in 2018
Figure Hospital
Figure Clinic
Figure Others
Figure Global Type I Hyperlipoproteinemia Drug Revenue (Million USD) (2014-2025)
Figure Global Type I Hyperlipoproteinemia Drug Production (K Pcs) (2014-2025)
Figure North America Type I Hyperlipoproteinemia Drug Market Size (Million USD) (2014-2025)
Figure Europe Type I Hyperlipoproteinemia Drug Market Size (Million USD) (2014-2025)
Figure China Type I Hyperlipoproteinemia Drug Market Size (Million USD) (2014-2025)
Figure Japan Type I Hyperlipoproteinemia Drug Market Size (Million USD) (2014-2025)
Figure Southeast Asia Type I Hyperlipoproteinemia Drug Market Size (Million USD) (2014-2025)
Figure India Type I Hyperlipoproteinemia Drug Market Size (Million USD) (2014-2025)
Table Type I Hyperlipoproteinemia Drug Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Type I Hyperlipoproteinemia Drug in 2018
Figure Manufacturing Process Analysis of Type I Hyperlipoproteinemia Drug
Figure Industry Chain Structure of Type I Hyperlipoproteinemia Drug
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Type I Hyperlipoproteinemia Drug Manufacturing Plants Distribution
Table Type I Hyperlipoproteinemia Drug Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Type I Hyperlipoproteinemia Drug Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Type I Hyperlipoproteinemia Drug Production (K Pcs) of Major Manufacturers (2014-2019)
Table Type I Hyperlipoproteinemia Drug Production Market Share of Major Manufacturers (2014-2019)
Figure Type I Hyperlipoproteinemia Drug Production Share by Manufacturers in 2018
Table Type I Hyperlipoproteinemia Drug Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Type I Hyperlipoproteinemia Drug Revenue Market Share of Major Manufacturers (2014-2019)
Figure Type I Hyperlipoproteinemia Drug Revenue Share by Manufacturers in 2018
Table Type I Hyperlipoproteinemia Drug Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Type I Hyperlipoproteinemia Drug Production by Regions 2014-2019 (K Pcs)
Table Global Type I Hyperlipoproteinemia Drug Production Market Share by Regions 2014-2019
Figure Global Type I Hyperlipoproteinemia Drug Production Market Share by Regions in 2018
Table Global Type I Hyperlipoproteinemia Drug Revenue by Regions 2014-2019 (Million USD)
Table Global Type I Hyperlipoproteinemia Drug Revenue Market Share by Regions 2014-2019
Figure Global Type I Hyperlipoproteinemia Drug Revenue Market Share by Regions in 2018
Table Global Type I Hyperlipoproteinemia Drug Consumption by Regions 2014-2019 (K Pcs)
Table Global Type I Hyperlipoproteinemia Drug Consumption Market Share by Regions 2014-2019
Figure North America Type I Hyperlipoproteinemia Drug Production Growth Rate 2014-2019 (K Pcs)
Figure North America Type I Hyperlipoproteinemia Drug Revenue Growth Rate 2014-2019 (Million USD)
Table North America Type I Hyperlipoproteinemia Drug Production, Consumption Import and Export (K Pcs)
Figure Europe Type I Hyperlipoproteinemia Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Type I Hyperlipoproteinemia Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Type I Hyperlipoproteinemia Drug Production, Consumption Import and Export (K Pcs)
Figure China Type I Hyperlipoproteinemia Drug Production Growth Rate 2014-2019 (K Pcs)
Figure China Type I Hyperlipoproteinemia Drug Revenue Growth Rate 2014-2019 (Million USD)
Table China Type I Hyperlipoproteinemia Drug Production, Consumption Import and Export (K Pcs)
Figure Japan Type I Hyperlipoproteinemia Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Type I Hyperlipoproteinemia Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Type I Hyperlipoproteinemia Drug Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Type I Hyperlipoproteinemia Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Type I Hyperlipoproteinemia Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Type I Hyperlipoproteinemia Drug Production, Consumption Import and Export (K Pcs)
Figure India Type I Hyperlipoproteinemia Drug Production Growth Rate 2014-2019 (K Pcs)
Figure India Type I Hyperlipoproteinemia Drug Revenue Growth Rate 2014-2019 (Million USD)
Table India Type I Hyperlipoproteinemia Drug Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Type I Hyperlipoproteinemia Drug Market Share by Application (2014-2019)
Figure Global Value (Consumption) Type I Hyperlipoproteinemia Drug Market Share by Application (2014-2019)
Table Aegerion Pharmaceuticals, Inc. Type I Hyperlipoproteinemia Drug Production Sites and Area Served
Table Aegerion Pharmaceuticals, Inc. Type I Hyperlipoproteinemia Drug Product Introduction, Application and Specification
Table Aegerion Pharmaceuticals, Inc. Type I Hyperlipoproteinemia Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Aegerion Pharmaceuticals, Inc. Type I Hyperlipoproteinemia Drug Production Growth Rate (2014-2019)
Table Aegerion Pharmaceuticals, Inc. Type I Hyperlipoproteinemia Drug Production Market Share (2014-2019)
Figure Aegerion Pharmaceuticals, Inc. Type I Hyperlipoproteinemia Drug Revenue Market Share (2014-2019)
Table Aegerion Pharmaceuticals, Inc. Type I Hyperlipoproteinemia Drug Main Business and Markets Served
Table Catabasis Pharmaceuticals, Inc. Type I Hyperlipoproteinemia Drug Production Sites and Area Served
Table Catabasis Pharmaceuticals, Inc. Type I Hyperlipoproteinemia Drug Product Introduction, Application and Specification
Table Catabasis Pharmaceuticals, Inc. Type I Hyperlipoproteinemia Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Catabasis Pharmaceuticals, Inc. Type I Hyperlipoproteinemia Drug Production Growth Rate (2014-2019)
Table Catabasis Pharmaceuticals, Inc. Type I Hyperlipoproteinemia Drug Production Market Share (2014-2019)
Figure Catabasis Pharmaceuticals, Inc. Type I Hyperlipoproteinemia Drug Revenue Market Share (2014-2019)
Table Catabasis Pharmaceuticals, Inc. Type I Hyperlipoproteinemia Drug Main Business and Markets Served
Table Isis Pharmaceuticals, Inc. Type I Hyperlipoproteinemia Drug Production Sites and Area Served
Table Isis Pharmaceuticals, Inc. Type I Hyperlipoproteinemia Drug Product Introduction, Application and Specification
Table Isis Pharmaceuticals, Inc. Type I Hyperlipoproteinemia Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Isis Pharmaceuticals, Inc. Type I Hyperlipoproteinemia Drug Production Growth Rate (2014-2019)
Table Isis Pharmaceuticals, Inc. Type I Hyperlipoproteinemia Drug Production Market Share (2014-2019)
Figure Isis Pharmaceuticals, Inc. Type I Hyperlipoproteinemia Drug Revenue Market Share (2014-2019)
Table Isis Pharmaceuticals, Inc. Type I Hyperlipoproteinemia Drug Main Business and Markets Served
Table Novartis AG Type I Hyperlipoproteinemia Drug Production Sites and Area Served
Table Novartis AG Type I Hyperlipoproteinemia Drug Product Introduction, Application and Specification
Table Novartis AG Type I Hyperlipoproteinemia Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Novartis AG Type I Hyperlipoproteinemia Drug Production Growth Rate (2014-2019)
Table Novartis AG Type I Hyperlipoproteinemia Drug Production Market Share (2014-2019)
Figure Novartis AG Type I Hyperlipoproteinemia Drug Revenue Market Share (2014-2019)
Table Novartis AG Type I Hyperlipoproteinemia Drug Main Business and Markets Served
Table uniQure N.V. Type I Hyperlipoproteinemia Drug Production Sites and Area Served
Table uniQure N.V. Type I Hyperlipoproteinemia Drug Product Introduction, Application and Specification
Table uniQure N.V. Type I Hyperlipoproteinemia Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table uniQure N.V. Type I Hyperlipoproteinemia Drug Production Growth Rate (2014-2019)
Table uniQure N.V. Type I Hyperlipoproteinemia Drug Production Market Share (2014-2019)
Figure uniQure N.V. Type I Hyperlipoproteinemia Drug Revenue Market Share (2014-2019)
Table uniQure N.V. Type I Hyperlipoproteinemia Drug Main Business and Markets Served
Figure Global Type I Hyperlipoproteinemia Drug Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Type I Hyperlipoproteinemia Drug Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Type I Hyperlipoproteinemia Drug Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Type I Hyperlipoproteinemia Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Type I Hyperlipoproteinemia Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Type I Hyperlipoproteinemia Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Type I Hyperlipoproteinemia Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Type I Hyperlipoproteinemia Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Type I Hyperlipoproteinemia Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Type I Hyperlipoproteinemia Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Type I Hyperlipoproteinemia Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Type I Hyperlipoproteinemia Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Type I Hyperlipoproteinemia Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Type I Hyperlipoproteinemia Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Type I Hyperlipoproteinemia Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Type I Hyperlipoproteinemia Drug by Type (2019-2025)
Table Global Consumption (K Pcs) of Type I Hyperlipoproteinemia Drug by Application (2019-2025)
Table Type I Hyperlipoproteinemia Drug Distributors List
Table Type I Hyperlipoproteinemia Drug Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介

予防喘息薬の世界市場：インサイト・予測

Global Preventive Asthma Drug Market Insights, Forecast to 2025
QYR9ST03007 2019年9月2日 118Pages
※本調査レポートでは、世界の予防喘息薬市場について調査・分析し、以下の構成でお届け致します。予防喘息薬の種類別には、ソマトスタチンアナログ、標的療法、化学療法に、用途別には、病院、診療所、腫瘍センターに、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフ...

高度ドラッグデリバリーシステムの世界市場：市場規模・現状・予測

Global Advanced Drug Delivery Systems Market Size, Status and Forecast 2019-2025
QYR9ST03812 2019年9月2日 94Pages
※当調査レポートでは、高度ドラッグデリバリーシステムの世界市場について調査・分析し、高度ドラッグデリバリーシステムの世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（経口ドラッグデリバリー、肺ドラッグデ...

ニードルフリードラッグデリバリーの世界市場：市場規模・現状・予測

Global Needle-Free Drug Delivery Market Size, Status and Forecast 2019-2025
QYR9ST04968 2019年9月2日 91Pages
※当調査レポートでは、ニードルフリードラッグデリバリーの世界市場について調査・分析し、ニードルフリードラッグデリバリーの世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（ジェットインジェクター、経皮ドラ...

ドラッグデリバリーにおけるナノテクノロジーの世界市場：市場規模・現状・予測

Global Nanotechnology in Drug Delivery Market Size, Status and Forecast 2019-2025
QYR9ST03692 2019年9月2日 99Pages
※当調査レポートでは、ドラッグデリバリーにおけるナノテクノロジーの世界市場について調査・分析し、ドラッグデリバリーにおけるナノテクノロジーの世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（対象配送、医...

抗体薬物コンジュゲートの世界市場：インサイト・予測

Global Antibody Drug Conjugates Market Insights, Forecast to 2025
QYR9ST00775 2019年9月2日 117Pages
※本調査レポートでは、世界の抗体薬物コンジュゲート市場について調査・分析し、以下の構成でお届け致します。抗体薬物コンジュゲートの種類別には、アドセトリス、カドシラに、用途別には、乳癌、リンパ腫に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなど...

がんワクチン薬パイプラインの世界市場：市場規模・現状・予測

Global Cancer Vaccines Drug Pipeline Market Size, Status and Forecast 2019-2025
QYR9ST04750 2019年9月2日 95Pages
※当調査レポートでは、がんワクチン薬パイプラインの世界市場について調査・分析し、がんワクチン薬パイプラインの世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（治療ワクチン、予防ワクチン）、用途別（外来診...

世界のテノフォビル/ラミブジン/アタザナビル/リトナビル併用薬市場：専門的調査

Global Tenofovir/Lamivudine/Atazanavir/Ritonavir Combination Drug Market Professional Survey Report 2019
QYR9ST08679 2019年9月5日 108Pages
※本調査レポートは、テノフォビル/ラミブジン/アタザナビル/リトナビル併用薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、10錠、30錠に、用途別には、病院...

世界のエベロリムス薬市場：専門的調査

Global Everolimus Drug Market Professional Survey Report 2019
QYR9ST06002 2019年9月2日 101Pages
※本調査レポートは、エベロリムス薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、2.5mg錠、5mg錠、10mg錠、分散錠に、用途別には、腎臓がん、臓器移植...

世界のエベロリムス薬市場：専門的調査

世界のエファビレンツ・テノフォビル・エムトリシタビン配合剤市場：専門的調査

Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Market Professional Survey Report 2019
QYR9ST06778 2019年9月5日 104Pages
※本調査レポートは、エファビレンツ・テノフォビル・エムトリシタビン配合剤の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、10テーブル、30テーブルに、用途別に...

アフィニトール薬の世界市場：インサイト・予測 Everolimus is the 40-O-(2-hydroxyethyl) derivative of sirolimus and works similarly to sirolimus as an inhibitor of mammalian target of rapamycin (mTOR).The global Afinitor Drug market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% duri…
レブリミド薬の世界市場：インサイト・予測 It was initially intended as a treatment for multiple myeloma, for which thalidomide is an accepted therapeutic treatment. Lenalidomide has also shown efficacy in the class of hematological disorders known as myelodysplastic syndromes (MDS).The global Revlimid Drug market is valued at xx million US$…
コセンティクス薬の世界市場：インサイト・予測 The global Cosentyx- Drug market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Cosentyx- Drug market based on company, product type, end…
レナリドミド薬の世界市場：インサイト・予測 It was initially intended as a treatment for multiple myeloma, for which thalidomide is an accepted therapeutic treatment. Lenalidomide has also shown efficacy in the class of hematological disorders known as myelodysplastic syndromes (MDS).The global Lenalidomide Drug market is valued at xx million…
世界のドルテグラビル・リルピビリン併用薬市場：専門的調査 The global Dolutegravir/Rilpivirine Combination Drug market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report focuses on Dolutegravir/Rilpivirine Combination Drug volume and value at global level, regional le…